Celprogen is engaged in the development of therapeutic products on cardiology, oncology, diabetes and neurology. Read more
ORIG3N is Celprogen, Inc.'s #1 rival. ORIG3N is a Private company that was founded in Boston, Massachusetts in 2014. ORIG3N competes in the Biotechnology field. ORIG3N has 40 more employees vs. Celprogen, Inc..
Medicure is perceived as one of Celprogen, Inc.'s biggest rivals. Medicure was founded in 1997, and is headquartered in Winnipeg, Manitoba. Medicure is in the Health Care Services field. Medicure generates $6.1M more revenue vs. Celprogen, Inc..
No recent acquisitions found related to Celprogen, Inc.
No recent funding data found related to Celprogen, Inc.
No recent investments found related to Celprogen, Inc.